Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.46 | -$0.45 | -$0.46 |
| Q2 2026 | 3 | -$0.30 | -$0.30 | -$0.30 |
| Q3 2026 | 3 | -$0.21 | -$0.21 | -$0.21 |
| Q4 2026 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q1 2027 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q2 2027 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q3 2027 | 1 | -$0.13 | -$0.12 | -$0.13 |
| Q4 2027 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q1 2028 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q2 2028 | 1 | $0.02 | $0.02 | $0.02 |
| Q3 2028 | 1 | $0.29 | $0.30 | $0.29 |
| Q4 2028 | 1 | $0.13 | $0.14 | $0.13 |
OrthoPediatrics corp last posted its earnings results on Thursday, April 30th, 2026. The company reported $-0.42 earnings per share for the quarter, missing analysts' consensus estimates of $-0.38 by $0.04. The company had revenue of 59.36 M for the quarter and had revenue of 236.35 M for the year. OrthoPediatrics corp has generated $-2 earnings per share over the last year ($-1.69 diluted earnings per share) and currently has a price-to-earnings ratio of -10.81. OrthoPediatrics corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/01/2026 | Q1 2026 | N/A | -$0.45 | N/A | $58.29 M | $59.36 M |
| 03/04/2026 | Q4 2025 | N/A | -$0.43 | N/A | $60.16 M | $61.61 M |
| 10/29/2025 | Q3 2025 | N/A | -$0.50 | N/A | $62.11 M | $61.25 M |
| 08/06/2025 | Q2 2025 | N/A | -$0.30 | N/A | $61.47 M | $61.08 M |
| 05/08/2025 | Q1 2025 | N/A | -$0.46 | N/A | $51.68 M | $52.41 M |
| 03/05/2025 | Q4 2024 | N/A | -$0.69 | N/A | $51.32 M | $52.67 M |
| 11/07/2024 | Q3 2024 | N/A | -$0.34 | N/A | $53.73 M | $54.57 M |
| 08/06/2024 | Q2 2024 | N/A | -$0.26 | N/A | $52.52 M | $52.80 M |
| 05/07/2024 | Q1 2024 | N/A | -$0.34 | N/A | $41.78 M | $44.69 M |
| 03/08/2024 | Q4 2023 | N/A | -$0.29 | N/A | N/A | $37.61 M |
| 11/07/2023 | Q3 2023 | N/A | -$0.20 | N/A | N/A | $39.97 M |
| 08/01/2023 | Q2 2023 | N/A | -$0.13 | N/A | N/A | $39.56 M |
| 05/02/2023 | Q1 2023 | N/A | -$0.30 | N/A | N/A | $31.59 M |
| 03/01/2023 | Q4 2022 | N/A | -$0.35 | N/A | N/A | $30.99 M |
| 11/01/2022 | Q3 2022 | N/A | $0.88 | N/A | N/A | $34.95 M |
| 08/04/2022 | Q2 2022 | N/A | -$0.02 | N/A | N/A | $32.93 M |
| 05/05/2022 | Q1 2022 | N/A | -$0.47 | N/A | N/A | $23.42 M |
| 03/03/2022 | Q4 2021 | N/A | $0.00 | N/A | N/A | $24.81 M |
| 11/04/2021 | Q3 2021 | N/A | -$0.11 | N/A | N/A | $25.08 M |
| 08/05/2021 | Q2 2021 | N/A | -$0.19 | N/A | N/A | $26.70 M |
The conference call for OrthoPediatrics corp's latest earnings report can be listened to online.
The conference call transcript for OrthoPediatrics corp's latest earnings report can be read online.
OrthoPediatrics corp (:KIDS) has a recorded annual revenue of $236.35 M.
OrthoPediatrics corp (:KIDS) has a recorded net income of $-39,648,000.OrthoPediatrics corp has generated $-1.69 earnings per share over the last four quarters.
OrthoPediatrics corp (:KIDS) has a price-to-earnings ratio of -10.81 and price/earnings-to-growth ratio is -7.5.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED